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Abstract
Cancers follow a clonal Darwinian evolution, with fitter subclones replacing more quies-
cent cells, ultimately giving rise to macroscopic disease. High-throughput genomics provides
the opportunity to investigate these processes and determine specific genetic alterations
driving disease progression. Genomic sampling of a patient’s cancer provides a molecular
history, represented by a phylogenetic tree. Cohorts of patients represent a forest of related
phylogenetic structures. To extract clinically relevant information, one must represent and
statistically compare these collections of trees. We propose a framework based on an ap-
plication of the work by Billera, Holmes and Vogtmann on phylogenetic tree spaces to the
case of unrooted trees of intra-individual cancer tissue samples. We observe that these tree
spaces are globally nonpositively curved, allowing for statistical inference on populations of
patient histories. A projective tree space is introduced, permitting visualizations of aggre-
gate evolutionary behavior. Published data from three types of human malignancies are
explored within our framework.
1 Introduction
A tumor is the result of successive accumulation of genetic alterations. As alterations accu-
mulate, cancer cells of higher fitness replace earlier populations and drive progression of the
disease. Senescence, apoptosis, immune surveillance, and drug treatment all represent selection
pressures in the evolutionary environment of tumor cells. Competitive survival among tumor
cells with periods of clonal replacement is a unifying characteristic of cancers, which are an
otherwise diverse set of diseases. Darwinian evolution of tumor populations explains many im-
portant observations such as dynamic allele fractions of mutations and acquired resistance to
chemotherapies. [9] A seminal paper by Peter Nowell in 1976 [15] first used the term “tumor
stemlines” in its thesis that cancers derive from a common progenitor and progress via sequential
selection among subclonal populations. It is increasingly being appreciated that the patterns of
clonal evolution can vary widely between cancer types and between treatment strategies. Learn-
ing how these processes develop and how alterations accumulate provides valuable information
in understanding the molecular mechanisms of oncogenesis and acquired drug resistance. A
nuanced picture of an individual’s tumor evolution may prove useful in predicting prognosis
and tailoring disease management.
In the last five years, high throughput sequencing has illuminated the landscape of genomic
alterations in a large number of tumors. The Cancer Genome Atlas (TCGA) and the Interna-
tional Cancer Genome Consortium (ICGC) have led this effort, sequencing thousands of tumors
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Figure 1: The dynamic nature of clonal evolution in cancer. We depict the evolution of a tumor
through various clinical stages, with time running from left to right. There is an expansion of
malignant cells beginning at “oncogenesis” and within the larger gray cell mass are contained
different subclonal populations, represented in different colors. The overall size of the malig-
nant cell mass is affected by therapeutic interventions, here depicted via symbols for radiation
treatment, targeted molecular agents, and salvage chemotherapy. The schematic shows a pro-
gression from oncogenesis through clinically distinct phases: primary tumor, remission following
initial therapy, relapse, remission following salvage therapy, and finally uncontrolled metastatic
spread. Sequencing may be performed at multiple clinical time points, however the mutational
spectrum primarily reflects the dominant clone at that time point.
spanning the spectrum of human malignancies, leading to the identification of recurrent alter-
ations that indicate mechanisms of convergent evolution in certain genes and pathways. Large
cross-sectional studies, however, are not designed to capture the dynamic nature of tumor evo-
lution. For this one needs longitudinal studies, sequencing a tumor at multiple time points
within an individual’s disease course, and such studies are only now emerging in the litera-
ture [7, 17, 19, 21]. Key questions in tumor dynamics surround the mechanisms of acquired
drug resistance, the emergence of subclones with metastatic potential, the clinical stratifica-
tion of patients according to observed tumor evolution, and the design of personalized drug
treatment regimens to steer tumor evolution.
The rise of dominant clones in a tumor can be inferred by sequential sequencing of an
individual’s disease. Successive genomic snapshots may represent defined temporal intervals,
progression of disease through predefined stages, or successive anatomic sites to which a cancer
has spread. In all of these scenarios we make observations about an evolutionary process and
can represent the relationships between genomic snapshots as a phylogenetic tree. When large
cohorts of cancer patients are studied, yielding a forest of such phylogenetic trees, we require a
mathematical framework in which to reason about aggregate evolutionary behaviors. We must
be able to, at a minimum, directly compare two evolutionary histories. We would like to be able
to define distances between trees, stratify patients according to the evolutionary trajectories of
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their cancer, and correlate different trees with prognostic variables and molecular markers. A
more ambitious aim would be to assess statistical significance on samples of trees and implement
machine learning algorithms which act directly upon forests of phyolgenetic structures. Here,
we apply the work of Billera, Holmes and Vogtmann [4] and Sturm [20] on geometric spaces of
phylogenetic trees to provide a framework for the visualization and quantitative summarization
of tumor evolutionary histories. Our work provides a compact language for biologists and
oncologists to use in describing longitudinal cancer genomic data sets.
We first describe the general space of tumor evolutionary histories and then elaborate on
the most common cases of having either three or four samples per patient. Section 2 describes
the topology and geometry of the tree spaces, along with the basic summary statistics they
allow, and also introduces a projective tree space that will underlie our visualizations. It
provides a theoretical background of the main concepts that will be applied in this and future
work. Section 3 demonstrates the application of the projective moduli spaces in visualizing the
aggregate evolutionary behavior of two hematologic malignancies, acute myeloid leukemia and
follicular lymphoma, as well as one solid tumor, pancreatic adenocarcinoma. We conclude by
discussing the exciting theoretical and applied frontiers that remain open in the development
of evolutionary moduli spaces for longitudinal cancer genomic data.
2 Description of the space of trees
We can understand the relation between m different genomes following clonal evolution as a
phylogenetic tree with m leaves. A phylogenetic tree is a weighted, connected graph with no
circuits, having m distinguished vertices of degree 1 labeled {1, . . . ,m}, and all other vertices
of degree ≥ 3. Edges that terminate in leaves are “external” edges and the remaining edges are
“internal”.
When the external branches all have length 0, the tree space we have described (where the
nonzero weights are on the internal branches) was introduced and studied by Billera, Holmes,
and Vogtmann. Specifically, the structure of the internal branches is captured by the BHVm−1
construction (where the m − 1 index arises from the fact that they consider rooted trees).
Allowing potentially nonzero weights for the m external leaves corresponds to crossing with an
m-dimensional orthant. Therefore, the space we wish to study is simply
Σm = BHVm−1 × (R≥0)m.
We refer to Σm as the evolutionary moduli space.
2.1 The metric geometry of evolutionary moduli spaces
As described above, the space Σm is just a set of points. The key insight of Billera, Holmes,
and Vogtmann is that this space is equipped with a natural metric that endows the space with
an intrinsic geometry.
The metric on BHVm−1 is induced from the standard Euclidean distance on each of the
orthants, as follows. For two trees t1 and t2 which are both in a given orthant, the distance
dBHVm−1(t1, t2) is defined to be the Euclidean distance between the points specified by the
weights. For two trees which are in different quadrants, there exist (many) paths connecting
them which consist of straight lines in each quadrant. The length of such a path is the sum
of the lengths of these lines, and the distance dBHVm−1(t1, t2) is then the minimum length over
all such paths. There is an analogous metric on Σm, which can be regarded as induced from
the metric on BHVm−1. Specifically, for a tree t, let t(i) denote the length of the external edge
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associated to the vertex i. Then
dΣm(t1, t2) =
√√√√dBHVm−1(t¯1, t¯2) + m∑
i=1
(t1(i)− t2(i))2,
where t¯i denotes the tree in BHVm−1 obtained by forgetting the lengths of the external edges
(e.g., see [18]).
The metric space (Σm, dΣm) allows us to talk meaningfully about the distance between two
evolutionary histories. But more importantly, dΣm allows us to describe the geometry of Σm,
specifically curvature. The curvature of a space can be seen in the behavior of triangles; given
side lengths (`1, `2, `3) ⊂ R3, a triangle with these side lengths on the surface of the Earth is
“fatter” than the corresponding triangle on a Euclidean plane. We can be more precise about
this by looking at the distance from a vertex of the triangle to a point p on the opposite side —
in a fat triangle, this distance will be larger than in the the corresponding Euclidean triangle.
(Thin triangles are defined analogously.)
Alexandrov observed that this perspective makes sense in any geodesic metric space [2]. A
metric space M is a geodesic metric space if any two points x and y can be joined by a path
with length precisely d(x, y). Then given points p, q, r, we have the triangle T = [p, q, r] with
edges the paths connecting each pair of vertices. These paths specify edge lengths, and so we
can find a corresponding triangle T˜ in Euclidean space. Given a point z on the edge [p, q], a
comparison point in T˜ is a point z˜ on the corresponding edge [p˜, q˜] such that d(z˜, p˜) = d(p, z).
We say that a triangle T in M satisfies the CAT(0) inequality if for every pair of points x
and y in T and comparison points x˜ and y˜ on T˜ , we have d(x, y) ≤ d(x˜, y˜). If every triangle
in M satisfies the CAT(0) inequality then we say that M is a CAT(0) space. More generally,
let Mκ denote the unique two-dimensional Riemannian manifold with curvature κ. Then we
say that a geodesic metric space M is CAT(κ) if every triangle in M satisfies the inequality
above for the comparison triangle in Mκ. Gromov gave a condition for a cubical complex to
be CAT(0), and using this condition Billera, Holmes, and Vogtmann showed that BHVm−1 is
CAT(0). An immediate generalization of their argument yields the analogous result for Σm.
Theorem 1. The space Σm is a CAT(0) space.
2.2 Statistics on evolutionary moduli spaces
Sequencing longitudinal cancer samples can be regarded as sampling from a distribution on
the evolutionary moduli space. Differences between the distributions associated with different
tumors can be used to predict different evolutionary trajectories. First, we must justify the use
of distributions on Σm. One can set up many aspects of the formal apparatus of probability
theory on any complete metric space with a countable dense subset (i.e., a Polish spaces).
Theorem 2. The space Σm is a Polish space.
There are many natural distributions on Σm (e.g., uniform selection of tree topology fol-
lowed by uniform selection of edge weights from a range [a, b]), although constructing biologically
meaningful distributions appears to be a challenging problem. The principal virtue of establish-
ing that Σm is a CAT(0) space is that in this context, there exist well-defined notions of mean
and variance, and more generally one can attempt to perform statistical inference. Holmes
has written extensively on this topic [10, 11, 12] in the specific context of tree spaces (and see
also [8]), and an account of basic statistical procedures for CAT(0) spaces in general has been
given by Sturm [20]. The correct notion of the mean of a set of points is a generalization of a
centroid: we define the Fre´chet mean and variance in Σm.
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Definition 1. Given a fixed set of n trees {T0, . . . Tn−1} ⊆ Σm, the Fre´chet mean T is the
unique tree that minimizes the quantity
E =
n−1∑
i=0
dΣm(Ti, T )
2.
The variance of T is the ratio En .
Sturm’s work provides an iterative procedure for computing the mean in Σm, and by ex-
ploiting the local geometric structure of Σm, Miller, Owen, and Provan produce somewhat more
efficient algorithms for computing the mean.
There are many natural test statistics defined in terms of the Fre´chet mean and candidate
inference algorithms that use the metric structure of tree space. One can use resampling and
Monte Carlo simulation to obtain confidence intervals and perform inference, but practical study
of such procedures and the development of the theoretical foundations for inference are both
active areas of inquiry (e.g., the recent work in the context of tree spaces [10, 11, 12, 3, 8]). In our
forthcoming paper [22], we develop and apply such techniques to inference and machine-learning
problems arising in the study of tumor evolution.
2.3 The projective evolutionary moduli spaces
We are primarily interested in classifying and comparing distinct evolutionary behaviors by un-
derstanding the relative lengths of edges: rescaling edge lengths does not change the relationship
between the branches. Thus, we will also use the quotient space of Σm by the equivalence rela-
tion that for each orthant, the tree {ti} is equivalent to the rescaled tree {λti}, i.e., the subspace
of Σm consisting of the points {ti} in each orthant for which the constraint
∑
i ti = 1 holds. We
will denote this quotient by PΣm, the evolutionary projective moduli space.
This space of trees (without external edges) of fixed length was studied by Boardman and
is denoted by τm−1. The space of m external branches that sum to a fixed length is an m − 1
dimensional simplex, which we denote Tm−1. As we are requiring that the length of internal
branches plus the external branches sum to a fixed constant, we can describe our space as the
join of τm−1 and Tm−1:
PΣm = τm−1 ? Tm−1.
Since for the applications we describe herein the trees have either 3 or 4 leaves, it is in-
structive to describe explicitly the spaces PΣ3 and PΣ4. In the case of 3 leaves all structure
is in the external branches and PΣ3 is a triangle. The triangle has three vertices and 3 edges;
below we provide biological interpretations for these regions of the space in the context of dif-
ferent experiments. In the case of four leaves, τ3 is a set of 3 points reflecting the three possible
topologies of unrooted 4-trees and PΣ4 becomes a richer space in which to compare and visualize
evolutionary modes.
There is a natural projection map Σm → PΣm given by rescaling. However, a number of
warnings apply to the use of this projection. Notably, PΣm is not a CAT(0) space (it is a
CAT(1) space). As a consequence, we cannot compute meaningful averages or variances in
general. Moreover, the metric structure on PΣm is complicated. Even for a single simplex ∆n,
treating ∆n as a subspace of Rn does not lead to sensible statistical procedures. In this case,
an approach to inference was introduced by Aitchison [1]. In work in progress we are studying
the integration of Aitchison’s transformation with PΣm.
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Figure 2: Evolutionary modes in PΣ3. A: frozen evolution, B: branched evolution, C: divergent
evolution, D: linear evolution, E: somatic hypermutation.
2.4 Triplet data
In the context of cancer patients, triplet samples are often comprised of 1) normal tissue, 2)
malignant tissue at diagnosis, and 3) malignant tissue at a later clinical time point such as
local relapse. The moduli space of unrooted phylogenetic 3-trees, Σ3, is a Euclidean 3-orthant
whose basis vectors represent the 3 external edge lengths (ln, ld, lr). We project each tree onto
PΣ3, the space formed by the intersection R3+∩S2, by rescaling the branch lengths. This space
is visualized in Figure 2
The general case of three nonzero external branch lengths is called branched evolution and
such phylogenetic trees will be found far from the boundary of PΣ3. We would also like to
understand the possible singular cases that occur when one or more branches degenerate. If
all branch lengths are zero then we have the trivial situation of no evolution among the three
samples.
The edges of PΣ3 represent trees in which a single branch has collapsed to zero. As ln → 0
we have the situation where the diagnosis and the relapse are completely distinct tumors whose
earliest common ancestor is in fact normal tissue. We call this divergent evolution. As ld → 0 we
have the situation where the diagnosis is a perfect intermediate between the normal and relapse
genotypes, the well known case of linear evolution. Lastly, as lr → 0 we have the situation
where the relapse sample is actually the intermediate between normal and diagnosis genotypes,
indicating the emergence of an ancient clone that was not dominant at the time of diagnosis.
We call this revertant evolution.
The vertices of PΣ3 represent trees in which two branches have collapsed to zero. Near the
“shared” vertex is the case where the tumor genomics are almost identical between diagnosis
and relapse samples with respect to normal tissue. From a clinical perspective, no further
mutations are needed beyond the diagnosis stage for the disease to relapse, and we term this
scenario frozen evolution. Near the “diagnosis” vertex is the case where the relapsed tumor is
almost identical to normal, healthy tissue with respect to the lesion at diagnosis. This would
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be a highly unusual set of genotypes to observe since advanced cancers require some genomic
deviation from normal. Near the “relapse” vertex is the case where the tumor at diagnosis
is essentially the same as normal tissue compared to the number of mutations specific to the
relapsed disease. Rapid accumulation of mutations can result from a shifting fitness landscape
during medical therapy, and this region of the space can indicate somatic hypermutation. This
scenario does not imply that the lesion at diagnosis has zero difference from normal tissue, but
rather that the difference is dwarfed by the number of mutations accumulated in the relapsed
sample.
2.5 Quadruplet data
Quadruplet samples can arise from 1) normal tissue, 2) malignant tissue at diagnosis, and 3)
malignant tissue at local relapse and 4) malignant tissue from distant metastasis. Unrooted
trees constructed from quadruplet data contain a single internal edge, implying 3 possible tree
topologies. We decompose the moduli space of unrooted phylogenetic 4-trees, Σ4, into the
product of spaces for its internal and external edges respectively, BHV3×R4+. Upon rescaling
of the branch lengths we project each tree onto PΣ4, the space formed by τ3 ? T3, which is the
join of a set of three points and a tetrahedron.
In Figure 3, we illustrate the two components of PΣ4. A quadruplet is represented by a
point in the star plot and a point in the tetrahedron. The three arms of the star plot represent
the three possible tree topologies, and they meet at an origin corresponding to the degenerate
case of a length zero internal branch. The vertices of the tetrahedron correspond to trees having
only one nonzero external branch, the edges to trees with two nonzero external branches, and
the faces to trees with three nonzero external branches.
2.6 Quintuplet data
Quintuplet samples might include 1) normal tissue, 2) malignant tissue at diagnosis, 3) ma-
lignant tissue at local relapse, 4) malignant tissue from distant metastasis, and 5) malignant
tissue collected at autopsy. Unrooted trees constructed from quintuplet data contain two in-
ternal edges, implying 15 possible topologies. We decompose the moduli space of unrooted
phylogenetic 5-trees, Σ5, into the product of spaces for its internal and external edges respec-
tively, BHV4 × R5+. Upon rescaling of the branch lengths we project each tree onto PΣ5, the
space formed by τ4 ? T4. The internal space of Σ5 can be thought of as a cone on τ4, the Pe-
tersen graph. This object is a cubic graph with no planar embedding whose shortest circuit is
5. In Figure 4 we have arranged the possible tree topologies along the 15 edges of τ4, and each
vertex corresponds to an intermediate point of rotations between three adjacent topologies. We
represented the space of external branches for triplet data as a 2–simplex, for quadruplet data
as a 3–simplex, and naturally for quintuplet data the space will be a 4–simplex, also called
a pentachoron. Explicit schemes for visualization of PΣ5 must encode the radial coordinate
along the cone on τ4 and also provide lower dimensional projections of the data residing in the
pentachoron.
From a visualization standpoint, the only impediment to explicit constructions of PΣm for
m ≥ 6 is the increasing dimensionality of the space. The number of possible topologies of an
unrooted phylogenetic tree on m samples grows as (2m− 5)!! and the overall dimension of Σm
is 2m− 3.
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Figure 3: Evolutionary modes in PΣ4. Each tree, A—E, is represented by a pair of points.
The three arms of the star plot specify the internal branch, and thus the topology, while the
tetrahedral plot describes the external branches.
3 Case Studies
We now turn to the recent cancer genomics literature for examples of different patterns of
tumor evolution. We examine the progression of two major hematologic malignancies for which
there is abundant triplet data: acute myelogenous leukemia and follicular lymphoma. Then we
shift to the highly aggressive solid tumors arising in the exocrine pancreas, pancreatic ductal
adenocarcinoma, for which there is publicly available quadruplet data. In each case study we
visualize aggregate evolutionary behavior and compute centroid trees via an implementation of
Definition 1 (Section 2.2) given by [14]. Useful acronyms for the ensuing sections are WGS
(whole genome sequencing) and WES (whole exome sequencing).
3.1 Relapsed acute myelogenous leukemia
Acute myelogenous keukemia (AML) accounts for about 80% of acute leukemia in adults with a
median survival time of less than three years, accounting for more than 1% of cancer deaths in
the US. AML is caused by the abnormal rapid growth of myelogenous progenitor cells interfering
with normal hematopoeisis. Most patients die from relapse after chemotherapy and subsequent
disease progression, with relapse free survival at only 40%. [16] The molecular mechanism of
relapse in AML is not fully understood. In a recent study of relapsed AML, [7] the evolution to
relapse was followed in 8 patients who received both induction and consolidation chemotherapy.
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Figure 4: The 15 possible tree topologies arranged on the edges of τ4 and color coded to
reflect biological plausibility. Warmer colors correspond to evolutionary relationships on the
five samples that would be highly surprising, such as normal tissue and the tumor at autopsy
being adjacent in the phylogeny.
The time to relapse varied between 235 - 961 days, and the investigators found that treatment
did not eliminate the original cancer clone in any of the patients. WGS was performed on all 8
patients and an average of 21 protein changing mutations per patient were revealed.
When mapped to PΣ3 all patients are near the “frozen evolution” vertex illustrating that
very few mutations were specific to either diagnosis or relapse samples (Figure 5). Despite
the genotypes being virtually shared between diagnosis and relapse, the latter is a far more
dangerous clinical entity. Also worth noting is the recurrence of mutations in genes that regulate
DNA methylation such as DNMT3A, IDH1, and IDH2. The combination of frozen evolution,
mutations that could affect global methylation patterns, and clinical progression of disease hints
that the majority of evolution in this cancer is occurring beyond the DNA level. Indeed, recent
reports suggest that relapse in AML is driven by epigenetic deregulation. [13]
3.2 Follicular lymphoma transformation to diffuse large B-cell lymphoma
Follicular lymphoma (FL) is a common lymphoid cancer, comprising 13% of all mature B-cell
neoplasms. Roughly 20% of FL cases undergo a histologic transformation to more aggressive
lymphoma phenotype resembling diffuse large B-cell lymphoma. While the prognosis of FL as
a whole is 80% at 5 years, the prognosis for tFL is far worse at 20% survival after 2 years. Two
recent genomic studies independently analyze patients with FL–tFL sample pairs and assess
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Figure 5: Frozen linear evolution from diagnosis to relapse observed in 8 AML patients. Patients
are represented by red circles, scaled by their total number of mutations. The centroid of the
distribution is represented as a gold star, and its associated phylogenetic tree is visualized.
the evolutionary behavior of the transformation. In the first paper, [19] WES was performed
on 12 patients, only 4 of whom had matched normal tissue. For the 8 patients in which somatic
mutations could not be reliably called, a panel of 52 genes with established roles in lymphoma-
genesis was used as a surrogate genotype. In the second paper, [17] WES was performed on 4
patients and WGS was performed on 6 patients. We pool this data into three distinct groups
based on genotype construction: WGS (6 patients), WES (8 patients), and curated gene panel
(8 patients).
The pooled data is visualized in Figure 6, with different colorings for the three groups.
Until recently there was no consensus on the evolutionary mode of FL–tFL transformation,
with some data even pointing to a linear process.[6] Figure 5, however, clearly demonstrates
that the majority of the data fall in the bulk of PΣ3 and represent a branched evolutionary
process. Comparison between the different genotype constructions further reveals that the
degree of branched vs. linear evolution observed depends on the data curation strategy.
3.3 Metastatic pancreatic cancer
Cancer of the exocrine pancreas accounts for roughly 85% of all pancreatic malignancies and is
the 4th leading cause of cancer-related deaths in the United States. In a recent study, [5] 13
cases of widely metastatic pancreatic ductal adenocarcinoma (PDAC) were studied at autopsy
using a genome-wide detection method of structural rearrangements. The anatomic sites repre-
sented among the metastases include liver, lung, diaphragm, adrenal glands, peritoneum, and
omentum.
We are interested in evolutionary histories involving distinct anatomical regions. To cast
this data as quadruplets of successive anatomic sites of disease, we consider the hypothesis that
the liver should represent the first metastatic location of PDAC. There is direct anatomical
communication between the exocrine pancreas and the liver, via the common bile duct, while
many of the other metastatic sites are only reachable via hematogenous spread of cancer cells.
Furthermore, the liver receives a large fraction of cardiac output and might therefore be respon-
sible for seeding the various more distant sites via the blood. For these reasons we are interested
in differentiating between metastases to the liver vs. other sites. We partition the large number
of samples per patient into the following disjoint subsets: normal tissue (1), primary pancreatic
10
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Figure 6: Different degrees of branched evolution observed in patients with FL–tFL transforma-
tion. Colored circles are scaled by patients’ total number of mutations. Genotype construction
strategy affects the degree of branched vs. linear evolution observed in WGS (red), WES
(green), and curated gene panel (blue). The centroids of the three distributions are represented
as gold stars, and their associated phylogenetic trees are visualized.
tumor (1), liver metastases (∼ 5), non-liver metastases (∼ 5).
All combinatorial 4-trees are inferred from this data and their mapping to PΣ4 is visualized
in Figure 7. We denote the normal tissue sample by N, the primary pancreatic tumor by P,
the liver metastases by LM, and the non-liver metastases by nLM. Contrary to our hypothesis
that liver metastases give rise to metastases in other tissues, we find that the centroid of the
data corresponds to a tree with branched ancestry between LM and nLM. Furthermore, we
observe that there is no branching in the progression from normal tissue to primary disease to
metastatic potential. In other words, the trajectory leading to the common ancestor of LM and
nLM is a linear one.
4 Conclusions
The recent surge in high throughput sequencing of cancer provides a window into the molecu-
lar events underlying oncogenesis, tumor progression, acquired drug resistance, and metastasis.
Longitudinal sampling of of an individual’s disease course is becoming more common and allows
us to interrogate the evolutionary history of a given tumor. Here we have proposed a framework
in which to analyze and compare sets of cancer evolutionary histories through a natural appli-
cation of the work on BHV spaces [4] to the setting of unrooted phylogenetic trees representing
sequential tissue samples from an individual’s disease. As the collection of longitudinal genomic
data sets accelerates, it will become unfeasible to directly reason about large forests of phylo-
genetic trees. Our framework directly aids in the visual and statistical exploration of tumor
evolutionary data with the goal of augmenting the intuition of cancer biologists and oncologists.
Exploring the distributions of evolutionary modes in different cancers can have implications for
personalized medical management and prognostication. For example, tuning the intensity of a
patient’s chemotherapeutic regimen requires an understanding of how treatment perturbs the
natural evolutionary path of the cancer.
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Figure 7: Both linear and branching behavior observed in 10 cases of metastatic PDAC. A
strong tendency toward (N,P),(LM,nLM) topology in is seen in the star plot on the left. The
majority of genetic alterations are acquired at the primary tumor stage. Evolution to LM and
nLM do not appear to be linearly related. The centroid of the distribution is represented as a
gold star, and its associated phylogenetic tree is visualized.
In this paper we have directly applied this framework to the analysis of three different cancers
exhibiting distinct evolutionary patterns. In the case of acute myelogenous leukemia the highly
localized distribution of patient histories in PΣ3 raises interesting questions about possible
mechanisms of relapse–associated evolution. Follicular lymphoma evolves as a highly branched
process, where the dominant clone in FL is not the direct ancestor of the dominant clone after
transformation. Lastly, in the case of pancreatic ductal adenocarcinoma the metastases appear
to derive linearly from the primary tumor, although the liver lesions and non–liver lesions branch
from a common ancestor.
Our efforts are now turning toward developing statistical and machine learning methods for
extracting meaningful biological and clinical information from point cloud data in Σm. Simula-
tions of archetypal evolutionary scenarios are also being developed in the service of performing
statistical inference on patient histories represented in our evolutionary moduli spaces [22]. One
particular goal of ours is to characterize shifts in point clouds as a function of drugs adminis-
tered to the patients, making use of clinically labeled data sets. From a patient management
standpoint one would like to quantify distances between sets of treated and un-treated tumor
histories and to look for correlations between regions of the space and clinical variables. The
falling cost of sequencing will permit ever denser sampling of cancer evolution, and creativity
will be needed if visualizations are to keep pace.
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